Literature DB >> 8797275

Loss of MHC I transcription trans-activator in the bovine B-LCL, BL3.1.

J S Harms1, G A Splitter.   

Abstract

BL3.1, a variant derived from the BLV infected bovine B cell line, BL3, is distinguished by a loss of expression of MHC class I. All surface MHC I products were down-regulated in BL3.1 compared with BL3 correlating with a diminution in MHC I heavy chain transcription. Class I genes, including regulatory elements, showed no aberrations. The variant, BL3.1, did not differ from the parent cell line in expression of Bovine Leukemia Virus (BLV) or oncogene, c-myc. Transient transfection experiments determined the defect was trans rather than cis, and was due to loss of a trans-activator rather than gain of a trans-suppressor as evidenced by transient heterokaryon fusions. Southwestern blot analysis indicated that two DNA binding proteins associated with the MHC class I promoter were missing in BL3.1 cells. The specific response elements for these proteins in BL3 did not appear to be within the enhancerA region, the major enhancer region of the MHC I promoter.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8797275     DOI: 10.1016/0165-2427(95)05503-7

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  1 in total

1.  Comparison of bovine leukemia virus (BLV) and CMV promoter-driven reporter gene expression in BLV-infected and non-infected cells.

Authors:  Jerome S Harms; Kurt A Eakle; Lillian S Kuo; Robert D Bremel; Gary A Splitter
Journal:  Genet Vaccines Ther       Date:  2004-08-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.